Gillette India Ltd Q1 FY27 Results Analysis: Revenue Grows 10.8%, Margin Compression Persists

CompoundingAI Research Updated July 31, 2026 2 min read
Neutral

Gillette India Ltd's Q1 FY27 numbers came in mixed, with revenue of Rs. 783.02 Cr (+10.80% YoY) and PAT growth of +9.44% YoY. Here's a quick read of what worked, what to watch, and what management said.

Quick Details
Results dateJuly 30, 2026
QuarterQ1 FY 2026-2027
Revenue (Q1)Rs. 783.02 Cr (+10.80% YoY)
PAT (Q1)Rs. 159.45 Cr (+9.44% YoY)
EBITDA margin29.09% (-66 bps YoY)
EPS (Q1)Rs. 48.93 (+9.44% YoY)
Market capRs. 25,156.22 Cr
CMPRs. 7,719.00

Quarter Snapshot

Gillette delivered 10.8% YoY revenue growth and 9.4% PAT growth, with oral care accelerating. However, margin compression from ad spend normalization and a sharp 25% YoY increase in employee costs, along with inventory build, temper the positive outlook. No management guidance was provided, limiting visibility on future performance.

Key Investment Insights

Key Positives

  • Revenue grew 10.80% YoY to Rs.783.02 Cr, accelerating from 3.2% in Q4FY26
  • Oral Care segment revenue grew 18.94% YoY, continuing strong momentum
  • PAT grew 9.44% YoY to Rs.159.45 Cr, with EPS of Rs.48.93
  • Cost of materials and purchases as a percentage of revenue remained stable at 36.05% vs 36.58% YoY
  • Effective tax rate stable at ~25.5%

Risk Factors

  • Employee benefits expense surged 25.12% YoY and 33.53% QoQ, outpacing revenue growth
  • EBITDA margin compressed 66 bps YoY to 29.09% and 592 bps QoQ due to ad spend normalization and employee cost spike
  • Grooming segment margin fell 761 bps QoQ to 27.59%
  • Oral Care segment margin compressed 393 bps YoY to 24.43% despite revenue growth
  • Inventory built by Rs.11.09 Cr in Q1, reversing a large drawdown last year, indicating increased working capital
Share on X · LinkedIn · WhatsApp

Disclaimer: This results analysis is published for educational and informational purposes only. It is not investment advice, not a recommendation to buy, sell or hold any security.

Powered by CompoundingAI — AI research platform for Indian stocks, every claim cited from primary filings

Login Now